Pete specialises in patent litigation, advising clients on complex disputes across a diverse range of technologies. He has extensive experience in handling complex and high value patent litigation before the UK courts (including up to the Supreme Court). His cases are frequently international in nature, and he often works with legal advisers from across Europe, North America and Asia, contributing to and often co-ordinating multi-jurisdictional patent litigation strategies.

Pete’s scientific background provides him with a firm understanding of technical issues. He is experienced in working with a diverse range of technologies, including medical devices, pharmaceutical products and formulations, biotechnology, telecommunications and engineering.

Pete frequently speaks on IP-related issues at conferences, including on SEP/FRAND litigation, for which he has been involved in a number of the leading cases in the UK. He is also a tutor on the Oxford Diploma in Intellectual Property Law and Practice course, teaching patent litigation.  

Pete became a partner in 2016.

Key cases: 

• Philip Morris v Nicoventures (heat-not-burn tobacco)
• Advanced Bionics v MED-EL (cochlear implants)
• Coloplast v Salts (ostomy devices)
• Unwired Planet v Huawei & Others (telecommunications / FRAND licensing)
• Garmin v Philips (GPS wearable devices)
• Varian v Elekta (MRI / radiotherapy devices)
• TCT v Ericsson (telecommunications)
• Mölnlycke v BSN Medical (wound dressings)
• ​Mylan v Sandoz (protein purification)
• Teva v Actavis (rasagiline)
• Icahn School of Medicine at Mount Sinai (SPCs – agalsidase beta)
• Corma v Hegler Plastik (extruded plastics)
• Eugen Seitz v KHS Corpoplast and Norgren (PET plastic technology)
• HTC v Apple (smartphones)
• Apple v Nokia (smartphones)
• Alan Nuttall v Fri-Jado (hot food merchandisers)
• Teva v Aventis (docetaxel formulations) 
• Roche v Chiron (SPCs – trastuzumab and enfuvirtide)